1,195 results on '"Meisel, Andreas"'
Search Results
2. Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohort
3. Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany
4. Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient’s perspective
5. POLAR: prediction of prolonged mechanical ventilation in patients with myasthenic crisis
6. Machine learning using multimodal and autonomic nervous system parameters predicts clinically apparent stroke-associated pneumonia in a development and testing study
7. Weaning and extubation failure in myasthenic crisis: a multicenter analysis
8. Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis
9. Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
10. Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering
11. Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension
12. Data lake-driven analytics identify nocturnal non-dipping of heart rate as predictor of unfavorable stroke outcome at discharge
13. Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study
14. Myasthenie bei Erwachsenen, Kindern und Jugendlichen – was ist neu?
15. Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
16. The structured ambulatory post-stroke care program for outpatient aftercare in patients with ischaemic stroke in Germany (SANO): an open-label, cluster-randomised controlled trial
17. Datawarehouse-enabled quality control of atrial fibrillation detection in the stroke unit setting
18. Prediction of Stroke Outcome in Mice Based on Noninvasive MRI and Behavioral Testing
19. Epidemiology and treatment of myasthenia gravis: a retrospective study using a large insurance claims dataset in Germany
20. Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis
21. The European Lambert–Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment
22. Seronegative myasthenic crisis: a multicenter analysis
23. Amphetamine and methylphenidate potential on the recovery from stroke and traumatic brain injury: a review
24. Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies
25. Functional Signature of LRP4 Antibodies in Myasthenia Gravis
26. Long-term Efficacy and Safety of Ravulizumab, a Long-acting Terminal Complement Inhibitor, in Adults with Anti-acetylcholine Receptor Antibody-positive Generalized Myasthenia Gravis: Final Results from the Phase 3 CHAMPION MG Open-label Extension (S15.010)
27. App and wearable-based remote monitoring for Myasthenia gravis patients and specialists: Feasibility and usability study (Preprint)
28. Burden of disease in myasthenia gravis: taking the patient’s perspective
29. Positionspapier Schlaganfallnachsorge der Deutschen Schlaganfall-Gesellschaft – Teil 1: Nachsorge nach einem Schlaganfall: Status quo der Versorgungsrealität und Versorgungsdefizite in Deutschland
30. Positionspapier Schlaganfallnachsorge der Deutschen Schlaganfall-Gesellschaft – Teil 2: Konzept für eine umfassende Schlaganfallnachsorge
31. Positionspapier Schlaganfallnachsorge der Deutschen Schlaganfall-Gesellschaft – Teil 3: Strukturelle Konzepte für zukünftige Versorgungsformen der Schlaganfallnachsorge
32. Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer’s disease
33. Development of a patient-oriented navigation model for patients with lung cancer and stroke in Germany
34. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients
35. Mental health in myasthenia gravis patients and its impact on caregiver burden
36. Myasthenia gravis - a retrospective analysis of e-mail inquiries made to a patient organisation and specialized center to uncover unmet needs from patients and caregivers
37. Robotic Extended Thymectomy
38. A supervised, externally validated machine learning model for artifact and drainage detection in high-resolution intracranial pressure monitoring data.
39. Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis.
40. Transfer RNA fragments replace microRNA regulators of the cholinergic poststroke immune blockade
41. Myasthenia gravis – Schritt für Schritt
42. A supervised, externally validated machine learning model for artifact and drainage detection in high-resolution intracranial pressure monitoring data
43. Myasthenia Gravis: Utilising cross-platform quantitative content analysis to uncover and validate unmet needs
44. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
45. Correction to: Burden of disease in myasthenia gravis: taking the patient’s perspective
46. Use of Pulmonary Computed Tomography for Evaluating Suspected Stroke-Associated Pneumonia
47. Abnormal brain structure and behavior in MyD88-deficient mice
48. CD4+ T cells promote delayed B cell responses in the ischemic brain after experimental stroke
49. Exploring the depths of IgG4: insights into autoimmunity and novel treatments.
50. Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.